GeneDx Holdings
268 hedge funds and large institutions have $3.24B invested in GeneDx Holdings in 2025 Q3 according to their latest regulatory filings, with 69 funds opening new positions, 86 increasing their positions, 82 reducing their positions, and 31 closing their positions.
123% more first-time investments, than exits
New positions opened: 69 | Existing positions closed: 31
16% more funds holding
Funds holding: 231 → 268 (+37)
12% more capital invested
Capital invested by funds: $2.91B → $3.24B (+$335M)
5% more repeat investments, than reductions
Existing positions increased: 86 | Existing positions reduced: 82
0% more funds holding in top 10
Funds holding in top 10: 11 → 11 (0)
5.62% less ownership
Funds ownership: 110.41% → 104.79% (-5.6%)
26% less call options, than puts
Call options by funds: $122M | Put options by funds: $164M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
+$48.7M |
| 2 |
Franklin Resources
San Mateo,
California
|
+$37.5M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$37M |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$34.5M |
| 5 |
NAMA
Nikko Asset Management Americas
New York
|
+$31.8M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$92.8M |
| 2 |
PCM
Pentwater Capital Management
Naples,
Florida
|
-$86.6M |
| 3 |
CC
Casdin Capital
New York
|
-$54.5M |
| 4 |
FAM
Fred Alger Management
New York
|
-$50.5M |
| 5 |
William Blair Investment Management
Chicago,
Illinois
|
-$44.8M |
WGS Hedge Fund Activity: Q3 2025 in Review
268 of the 7,640 institutional investors tracked by Wall St. Rank reported a position in GeneDx Holdings (WGS) for Q3 2025, worth a combined $3.24B — up 12% from $2.91B a quarter earlier.
Buyers outnumbered sellers: 69 funds opened new WGS positions and 31 closed out — a net gain of 38 holders — while 86 added to existing stakes and 82 trimmed.
The largest buyer was ARK Investment Management, opening a new position worth an estimated $48.7M. The largest seller was UBS Group, cutting an estimated $92.8M.
- 268 institutional investors held GeneDx Holdings (WGS) as of Q3 2025, up from 231 in Q2 2025.
- Funds reported $3.24B of GeneDx Holdings stock for Q3 2025, up 12% quarter-over-quarter.
- 69 funds opened new GeneDx Holdings positions in Q3 2025 and 31 closed out, a net change of +38 holders.
- The largest GeneDx Holdings buyer in Q3 2025 was ARK Investment Management, an estimated $48.7M added.
- The largest GeneDx Holdings seller in Q3 2025 was UBS Group, an estimated $92.8M sold.
Based on aggregated 13F filings for Q3 2025.